0001741638-21-000002.txt : 20210622 0001741638-21-000002.hdr.sgml : 20210622 20210622165845 ACCESSION NUMBER: 0001741638-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210622 DATE AS OF CHANGE: 20210622 EFFECTIVENESS DATE: 20210622 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-403839 FILM NUMBER: 211036025 BUSINESS ADDRESS: STREET 1: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 425 PONTIUS AVE N, STE 202 CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 D 1 primary_doc.xml X0708 D LIVE 0001808805 Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 SEATTLE WA WASHINGTON 98109 206-333-2001 DELAWARE ARYA Sciences Acquisition Corp III Corporation true 2020 Sujal Patel c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Executive Officer Director Parag Mallick c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Executive Officer Director Vijay Pande c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Director Farzad Nazem c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Director Matthew Posard c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Director Anna Mowry c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Executive Officer Melissa Epperly c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Director Michael Altman c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Director Matthew S. McIlwain c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Director Nicholas Nelson c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Executive Officer Subra Sankar c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Executive Officer Matthew Murphy c/o Nautilus Biotechnology, Inc. 425 PONTIUS AVE N, STE 202 Seattle WA WASHINGTON 98109 Executive Officer Other Decline to Disclose 06b false 2021-06-09 false true false 0 Jefferies LLC 2347 None None 520 Madison Avenue New York NY NEW YORK 10022 All States false Goldman Sachs & Co. LLC 361 None None 200 West Street New York NY NEW YORK 10282-2198 All States false 200000000 200000000 0 false 38 2000000 0 $1,000,000 in commission fees were paid to each Goldman Sachs & Co. LLC and Jefferies LLC. 0 false Nautilus Biotechnology, Inc. /s/ Sujal Patel Sujal Patel Chief Executive Officer 2021-06-22